RxDoctor Payments Data

Oluwafunmilola Okuyemi, MD

Otolaryngology · Las Vegas, NVNPI 1508027665

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Stryker accounts for 83.8% of it on its own, with 19 other manufacturers making up the rest. Among otolaryngology clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$59,708in general payments, 2019–2025

Across 149 payments — averaging $400.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$50K
  • Intuitive Surgical$8K
  • Medtronic$268
  • Smith+Nephew$209
  • Acera Surgical, Inc.$127
  • Polynovo North America LLC$115
  • plus $591 from 14 others

What the payments were for

  • Consulting fees$34,71358%
  • Travel & lodging$16,74128%
  • Food & beverage$3,6476%
  • Education$4,6078%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,708 in reported general payments places this provider in the 95th percentile of 41 otolaryngology providers in Nevada.

See all otolaryngology providers in Nevada

Medicare billing

Part B allowed, 2024
$55,050
Medicare patients
117
Services billed
389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium69$555
Gabapentin16$133

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →